Perspective Therapeutics, Inc.
CATX
$2.99
-$0.13-4.17%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -116.43M | -111.13M | -103.12M | -105.80M | -94.95M |
| Total Depreciation and Amortization | 4.05M | 3.64M | 3.24M | 2.94M | 2.84M |
| Total Amortization of Deferred Charges | 7.00K | 7.00K | 7.00K | -- | -- |
| Total Other Non-Cash Items | 17.31M | 16.60M | 15.71M | 28.81M | 28.68M |
| Change in Net Operating Assets | 2.01M | -1.48M | 1.68M | -10.40M | -1.35M |
| Cash from Operations | -93.07M | -92.37M | -82.48M | -84.43M | -64.78M |
| Capital Expenditure | -28.12M | -14.95M | -12.75M | -22.29M | -50.01M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -23.89M | -47.81M | 53.98M | -103.96M | -119.97M |
| Cash from Investing | -52.01M | -62.76M | 41.23M | -125.91M | -169.64M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -54.00K | -54.00K | -52.00K | -51.00K | -54.00K |
| Issuance of Common Stock | 164.77M | 164.75M | 10.36M | 10.71M | 11.13M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 164.71M | 164.70M | 10.31M | 10.66M | 11.08M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 19.64M | 9.57M | -30.95M | -199.68M | -223.34M |